Search results
677 results found
ISOF
3591Reference standard for (N-[4-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)- butyl]-2-(2-[¹⁸F]fluoro-ethoxy)-5-methyl-benzamide
N-[6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl-butyl]-2-(2-fluoro-ethoxy)-5-methyl-benzamide; N-[4-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-butyl]-2-(2-fluoro-ethoxy)-5-methyl-benzamide
Cu-DOTA-TOC
9698Reference material for the identification of contaminants in radiochemical preparations based on DOTA-TOC
Cu-DOTA-[Tyr3]octreotide
L-FEAU
2874Reference standard for [¹¹C]L-FEAU and [¹⁸F]L-FEAU (2'-[¹⁸F]fluoro-5-ethyl-1-β-L-arabinofuranosyluracil)
1-(2-Deoxy-2-fluoro-β-L-arabinofuranosyl)-5-ethyluracil; 1-(2-Deoxy-2-fluoro-β-L-arabinofuranosyl)-5-ethyl-2,4(1H,3H)-pyrimidinedione; 1-(2-Deoxy-2-fluoro-arabinofuranosyl)-5-ethyluracil; 2'-Fluoro-5-ethyl-arabinosyluracil; 2'-Fluoro-5-ethyl-β-L-arabinofuranosyluracil; 1-[(2S,3R,4S,5S)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-ethylpyrimidine-2,4-dione; 5-Ethyl-1-[(2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione; 5-Ethyl-1-(2-fluoro-2-deoxy-β-L-arabinofuranosyl)uracil; 1-(2-Deoxy-2-fluoro-β-L-arabinofuranosyl)-5-ethyl-2,4(1H,3H)-pyrimidinedione; β-L-FEAU
Thyronamine Hydrochloride
3035Metabolite of thyroid hormone
T0AM; Thyronamine Hydrochloride; 4-(4-Hydroxyphenoxy)phenethylamine Hydrochloride; 4-[4-(2-Amino-ethyl)-phenoxy]-phenol Hydrochloride
4-Fluoronaphthol standard
2541Reference standard for 4-[¹⁸F]Fluoronaphthol
1-Fluoro-4-hydroxynaphthalene; 4-Fluoro-1-naphthalenol; 4-[¹⁸F]Fluoronaphthol standard; 4-Fluoronaphthol standard
FBEM standard
4399Reference standard for [¹⁸F]FBEM (N-[2-(4-[¹⁸F]-fluorobenzamido)ethyl]-maleimide)
N-[2-(4-[¹⁸F]-fluorobenzamido)ethyl]-maleimide; N-[2-(2,5-Dioxo-2,5-dihydro-pyrrol-1-yl)-ethyl]-4-fluoro-benzamide
5'-O-Benzoyl-2,3'-anhydrothymidine
1230Precursor for [¹⁸F]FLT (3'-deoxy-3'-[¹⁸F]fluorothymidine)
5'-O-Benzoyl-2,3'-anhydrothymidine; 2,5-Methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one, 3-[(benzoyloxy)methyl]-2,3-dihydro-8-methyl-, (2R,3R,5R)-; (2R,3R,5R)-3-[(benzoyloxy)methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one; BATH
DFO*
7271Complexation agent for [⁸⁹Zr]-Labelling, immuno-PET
Disodium sulfosalicylate
7312Reagent for the preparation of [99mTc-Tracer]Tetrofosmin
5-Sulfosalicylic acid disodium salt; Disodium 5-sulfosalicylate; 2-(Sulfooxy)benzoic acid disodium salt; Salicylsulfonic acid disodium salt; Salicylsulfuric acid disodium salt
MDL105725
1840Precursor for [¹¹C]MDL100907
(R)-(+)-α-(3-Hydroxy-2-methoxyphenyl)-1-[2-(4-fluoro-phenyl)ethyl]-4-piperidine methanol; Desmethyl-MDL100907
3-Fluoropropyltosylate
6190Reference standard for 3-[¹⁸F]Fluoropropyltosylate
1-Fluoro-3-tosyloxypropane; 3-Fluoropropyl 4-toluenesulfonate; Toluene-4-sulfonic acid 3-fluoropropyl ester
HYNIC-cyclo(RGDfK) trifluoroacetate
9864Precursor for radiolabelled HYNIC-RGD.
HYNIC-cyclo-RGD; CA index name: Cyclo[L-arginylglycyl-L-α-aspartyl-D-phenylalanyl-N⁶-[(6-hydrazinyl-3-pyridinyl)carbonyl]-L-lysyl]
2-O-(Trifluoromethylsulfonyl)-1,3,5-tri-O-benzoyl-α-D-ribofuranose
2870Precursor 1 for [¹⁸F]FEAU and [¹⁸F]FMAU (FEAU = 2'-fluoro-5-ethyl-1-β-D-arabinofuranosyluracil; FMAU = 2'-deoxy-2'-fluoro-5-methyl-1-β-D-arabinofuranosyluracil)
1,3,5-Tri-O-benzoyl-2-O-(trifluoromethanesulfonyl)-α-D-ribofuranose; (2-O-(Trifluoromethylsulfonyl)-1,3,5-tri-O-benzoyl-α-D-ribofuranose)
T807 standard
5144Reference standard for [18F]T807
[18F]T807 standard
TAP
3300Precursor for [¹²³I]IAP
5-TMSt-A85380; (2S)-2-[[5-Trimethylstannyl-3-pyridinyloxy]methyl]-1-azetidinecarboxylic acid, tert-butyl ester
(R)-FPSPPA
2460Precursor for (R)-[¹¹C]-Methyl-FPSPPA (2-[(2-fluorophenyl)methyl]-3-(2-fluorospiro[4,5-dihydrothieno [2,3-c]pyran-7,40-piperidine]-10-yl)propanamide)
(2R)-2-[(2-Fluorophenyl)methyl]-3-(2-fluorospiro[4,5-dihydrothieno [2,3-c]pyran-7,40-piperidine]-10-yl)propanamide
N-Trifluoroacetyl-3,4-di-tert-butoxycarbonyloxy-6-trimethylstannyl-phenethylamine
1371Precursor for 6-[¹⁸F]Fluorodopamine
N-trifluoroacetyl-(3,4-O-di-Boc-6-trimethylstannylphenyl)ethylamine
Ubiquicidin (29-41) acetate
9600Precursor for [99mTc]Ubiquicidin (29-41)
(29-41)-Ubiquicidin
Metaraminol bitartrate
3390Precursor for [¹¹C]Metahydroxyephedrine
Metaraminol bitartrate salt; m-Hydroxy-norephedrine bitartrate; (–)-1-α-(1-Aminoethyl)-m-hydroxybenzylalcohol bitartrate; (–)-Metraminol (+)-bitartrate; (–)-m-Hydroxyphenylpropanolamine bitartrate salt; (–)-Metaraminol bitartrate
DOTAM-(CH₂)₄NH₂
7304Cation complexation agent
Tetraazacyclododecane-1,4,7,10-tetrakis (N-butylenamine acetamide)
(R,S)-O-Desmethylraclopride hydrobromide
1502Precursor for [¹¹C]Raclopride
3,5-Dichloro-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2,6-dihydroxy-benzamide hydrobromide
FB precursor (GMP)
4395Precursor for [¹⁸F]FB (4-[¹⁸F]fluorobenzoic acid)
4-(Ethoxycarbonyl)-N,N,N-trimethylbenzenaminium triflate; 4-(Ethoxycarbonyl)-N,N,N-trimethylbenzenaminium salt with trifluoromethanesulfonic acid; Methanesulfonic acid, trifluoro-, ion(1-), 4-(ethoxycarbonyl)-N,N,N-Trimethylbenzenaminium
[Lys5(Boc)]lanreotide acetate
9902Precursor for N-terminal substituted lanreotide analogs
[Lys5(Boc)]lanreotide; CA index name: L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-N⁶-[(1,1-dimethylethoxy)carbonyl]-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2→7)-disulfide
[¹⁸F]N-Methyl Lansoprazole Precursor
5148Precursor for [¹⁸F]N-Methyl Lansoprazole
2-[4-(2,2-Difluoro-vinyloxy)-3-methyl-pyridin-2-ylmethanesulfinyl]-1-methyl-1H-benzoimidazole; [¹⁸F]NML precursor
Y-DOTA-TOC
9704Reference Standard for [⁹⁰Y]Y-DOTA-TOC
natY-Edotreotide; natY-SMT487; natY-DOTA-[Tyr3]octreotide; Yttrium, [N-[2-[4,7,10-tris[(carboxy-κO)methyl]-1,4,7,10-tetraazacyclododec-1-yl-κN¹,κN⁴,κN⁷,κN¹⁰]acetyl-κO]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2→7)-disulfidato(3-)]-
